The Chiesi Group, the pharmaceutical group and Benefit Corporation with over 6,000 employees and 2.4 billion euros of turnover, has for some years embarked on a path that unites sustainability and social innovation in order to drive change in a sector where attention towards green issues needs to be combined with compliance with severe regulations for the safety of consumers/patients.